Verastem (VSTM) Cash from Investing Activities (2011 - 2026)
Verastem (VSTM) posted quarterly Cash from Investing Activities of -$16.0 million for Q1 2026, down 1090.71% quarter-over-quarter from -$1.3 million in Q4 2025.
Analysis
Verastem (VSTM) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Verastem's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$16.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$16.0 million; the TTM figure through Mar 2026 stood at -$17.4 million (changed N/A YoY), while the FY2025 annual figure was -$9.6 million, down 116.05% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$16.0 million, down from -$1.3 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $31.0 million in Q1 2024, with the low at -$70.1 million in Q3 2023.
- The 5-year median for Cash from Investing Activities is $12.7 million (2022), against an average of $5.4 million.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities surged 19634.85% in 2022, then sank 1608.05% in 2023.
- Verastem's Cash from Investing Activities stood at $13.0 million in 2022, then decreased by 4.52% to $12.4 million in 2023, then surged by 133.14% to $29.0 million in 2024, then plunged by 104.64% to -$1.3 million in 2025, then plunged by 1090.71% to -$16.0 million in 2026.
- Business Quant data shows VSTM's Cash from Investing Activities at -$16.0 million in Q1 2026, -$1.3 million in Q4 2025, and $29.0 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn | 16.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.25 Mn |
| Mar 31, 2026 | -16.02 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Jun 30, 2024 | 28.99 Mn |
| Mar 31, 2024 | 30.98 Mn |
| Dec 31, 2023 | 12.44 Mn |
| Sep 30, 2023 | -70.08 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | -804,000.00 |
| Dec 31, 2022 | 13.03 Mn |
| Sep 30, 2022 | 4.65 Mn |
| Jun 30, 2022 | 29.25 Mn |
| Mar 31, 2022 | 19.26 Mn |
| Dec 31, 2021 | 66,000.00 |
| Sep 30, 2021 | 10.00 Mn |
| Jun 30, 2021 | 2.39 Mn |
| Mar 31, 2021 | -12.37 Mn |
| Dec 31, 2020 | -79.38 Mn |
| Sep 30, 2020 | -6,000.00 |
| Jun 30, 2020 | -27,000.00 |